Can Methotrexate Cause Hair Thinning?
Yes, methotrexate can cause hair loss or hair thinning, though this is typically a manageable side effect that occurs relatively frequently with low-dose therapy.
Evidence from FDA Drug Labeling and Guidelines
The FDA drug label does not specifically list hair loss as a major toxicity requiring monitoring, but it is a recognized adverse effect 1. The British Association of Dermatologists' 2016 guidelines for methotrexate prescribing in skin disease do not list hair loss among the serious toxicities requiring urgent medical attention, suggesting it is considered a minor rather than severe adverse effect 2.
Clinical Evidence and Frequency
Hair loss occurs in approximately 29.4% of patients receiving immunomodulatory doses of methotrexate, based on a 2019 survey study of 68 patients treated for dermatologic conditions. Women were more commonly affected (60% of those reporting hair loss) 3. This is consistent with older literature documenting hair loss as a common minor side effect 4, 5.
The hair loss can manifest as:
- Diffuse thinning (most common pattern)
- Telogen effluvium (hair shedding)
- Can occur even with single-dose therapy (documented in ectopic pregnancy treatment at 50 mg/m²) 6
Management Strategy
Folic acid supplementation is the primary mitigation strategy and is recommended for all patients on methotrexate 2, 7. The 2024 pediatric consensus guidelines specifically state that "drug-related adverse effects of MTX including gastrointestinal effects, oral mucositis, fatigue, and headache are typically mitigated with folic acid supplementation" 7, and while hair loss isn't explicitly mentioned in this statement, it falls into the category of minor MTX-related effects that respond to folate.
Recommended approach:
- Daily folic acid 1 mg is preferred over once-weekly dosing 7
- Hair loss is generally reversible upon drug discontinuation 6
- Does not require stopping methotrexate unless severe or distressing to the patient
- Not considered a sign of serious toxicity requiring urgent intervention
Key Clinical Pearls
- Hair loss with methotrexate is a cosmetic rather than dangerous side effect
- It should be distinguished from the serious dermatologic reactions (Stevens-Johnson syndrome, toxic epidermal necrolysis) that require immediate drug cessation 1
- Patients should be counseled about this possibility before starting therapy as part of informed consent
- The effect is dose-related but can occur even at low immunomodulatory doses (7.5-15 mg/week for rheumatoid arthritis)
When counseling patients, inform them that hair thinning may occur but is typically mild, manageable with folic acid supplementation, and reversible if the medication needs to be stopped.